Drugs / Ondanesterone
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT06810531 Comparator | Feb → Jul 2025 | — | Aiman Al-Touny | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ondanesterone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06810531 ↗ |
| Route | Intravenous | “The drugs will be slowly injected intravenous 15 minute from spinal anesthesia.” NCT06810531 ↗ |